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ABSTRACT 
Purpose: Currently, identified factors for urethral recurrence (UR) are based on individual 
reporting which has displayed controversy. In addition, risk of UR is one of the limiting factors 
to offer neobladder diversion during radical cystectomy (RC). We aim to systematically 
evaluate the incidence and risk factors of UR post-RC and its effect on survival. Materials and 
methods: A systematic online search was conducted according to PRISMA statement for 
publications reporting on UR after RC. From initial 802 results, 14 articles including 6169 
patients were included finally after exclusion of ineligible studies. Results: The incidence rate 
of UR was 4.4% (1.3%–13.7%). It was significantly lower with neobladder diversion (odds 
ratio = 0.44, 95% CI: 0.24–0.79, P = 0.006). Muscle invasion (hazard ratio = 1.18, 95% CI: 
0.86–1.62, P = 0.31), carcinoma in situ (hazard ratio 0.97, 95% CI: 0.64–1.47, P = 0.88), 
prostatic stromal involvement (hazard ratio = 2.26, 95% CI: 0.01–627.75, P = 0.78), and 
prostatic urethral involvement (hazard ratio = 2.04, 95% CI: 0.20–20.80, P = 0.55) have no 
significant effect on UR. Men displayed tendency toward higher incidence of UR (odds ratio 
= 2.21, 95% CI: 0.96–5.06, P = 0.06). Absence of recurrence displayed tendency toward better 
disease specific survival, yet not significant (hazard ratio = 0.84, 95% CI: 0.66–1.08, P = 0.17). 
These results are limited by the retrospective nature of the included studies. Conclusion: 
Muscle invasion, carcinoma in situ and prostatic stromal or urethral involvement at time of RC 
have no significant effect on UR. Orthotopic neobladder is associated with a significant lower 
risk of UR after RC. 
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